Hemoglobin A1c Variability Predicts Symptoms of Depression in Elderly Individuals With Type 2 Diabetes
Ramit Ravona-Springer1,2, Anthony Heymann3, James Schmeidler4
1The Joseph Sagol Neuroscience Center, Sheba Medical Center, Ramat Gan, Israel ramit.ravona@sheba.health.gov.il ramitrs@hotmail.com.
Insights
High variability in hemoglobin A1c (HbA1c) levels over time is linked to increased depressive symptoms in adults with type 2 diabetes. Managing glycemic control variability may help mitigate depression risk.
Area of Science:
- Endocrinology
- Psychiatry
- Gerontology
Background:
- Type 2 diabetes management requires consistent glycemic control, often measured by hemoglobin A1c (HbA1c).
- Glycemic variability, specifically the standard deviation of HbA1c (HbA1c-SD), has been implicated in diabetes complications.
- Depressive symptoms are a common comorbidity in older adults with chronic conditions like diabetes.
Purpose of the Study:
- To investigate the association between long-term glycemic control variability and the presence of depressive symptoms.
- To determine if HbA1c variability, independent of mean HbA1c levels, predicts depressive symptoms in older adults with type 2 diabetes.
Main Methods:
- Utilized data from 837 participants in the Israel Diabetes and Cognitive Decline (IDCD) study.
- Assessed depressive symptoms using the Geriatric Depression Scale (GDS).
- Quantified glycemic control variability using the standard deviation of HbA1c measurements (HbA1c-SD) collected since 1998, analyzed via negative binomial regression.
Main Results:
- A significant positive correlation was found between mean HbA1c and HbA1c-SD (r = 0.6625; P < 0.0001).
- HbA1c-SD, but not mean HbA1c, was significantly associated with the number of depressive symptoms.
- Each 1% increase in HbA1c-SD corresponded to a 1.31-fold increase in depressive symptoms (IRR = 1.31 [95% CI 1.03-1.67]; P = 0.03).
Conclusions:
- Glycemic control variability, as measured by HbA1c-SD, is a significant predictor of depressive symptoms in older adults with type 2 diabetes.
- These findings highlight the importance of stable glycemic control beyond average HbA1c levels for mental health in diabetic patients.
Objective:
This study aimed to analyze the relationship of variability in hemoglobin A1c (HbA1c) over years with subsequent depressive symptoms.
Research Design And Methods:
Subjects (n = 837) were participants of the Israel Diabetes and Cognitive Decline (IDCD) study, which aimed to examine the relationship of characteristics of long-term type 2 diabetes with cognitive decline. All pertain to a diabetes registry established in 1998, which contains an average of 18 HbA1c measurements per subject. The results presented here are based on the IDCD baseline examination. Symptoms of depression were assessed using the 15-item version of the Geriatric Depression Scale (GDS). To quantify the association between variability in glycemic control (measured as the SD of HbA1c measurements [HbA1c-SD]) since 1998 with the number of depression symptoms at IDCD baseline, incidence rate ratios (IRRs) and corresponding 95% CIs were estimated via negative binomial regression modeling and used to account for the overdispersion in GDS scores.
Results:
Subjects' ages averaged 72.74 years (SD 4.63 years), and the mean number of years in the diabetes registry was 8.7 (SD 2.64 years). The mean GDS score was 2.16 (SD 2.26); 10% of subjects had a GDS score ≥6, the cutoff for clinically significant depression. Mean HbA1c significantly correlated with HbA1c-SD (r = 0.6625; P < 0.0001). The SD, but not the mean, of HbA1c measurements was significantly associated with the number of subsequent depressive symptoms. For each additional 1% increase in HbA1c-SD, the number of depressive symptoms increased by a factor of 1.31 (IRR = 1.31 [95% CI 1.03-1.67]; P = 0.03).
Conclusions:
Variability in glycemic control is associated with more depressive symptoms.
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Psychoneuroimmunology: Diabetes and Cancer
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...


